Skip to content

Clinical trials

Observational Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Observational Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20141
20181
20191
20202
20211
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Keele University1
Kiadis Pharma1
Nottingham University Hospitals NHS Trust1
Novartis Pharmaceuticals1
Pennine Acute Hospitals NHS Trust1
Pfizer1
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust1
University College, London1
University of East Anglia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
COVID-191
Cardiovascular Diseases1
Graft vs Host Disease1
Hematologic Neoplasms1
Joint Instability1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Respiration Disorders1
Shoulder Dislocation1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.